Login to Your Account



Algeta Grosses $41M In IPO To Advance Alpharadin Trials

By Cormac Sheridan


Wednesday, March 28, 2007
Algeta ASA's IPO on the Oslo Stock Exchange hit the upper end of its target, raising gross proceeds of slightly less than NOK250 million (US$41.1 million). (BioWorld International)

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription